Intrinsic axonal degeneration pathways are critical for glaucomatous damage

Experimental Neurology

Volumn 246, Issue , 2013, Pages 54-61

  Howell, Gareth R ^a   Soto, Ileana ^a   Libby, Richard T ^b   John, Simon W M ^a,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Axon; BAX; Glaucoma; Microglia; Optic nerve; Optic nerve head; Retinal ganglion cell; Wlds

Indexed keywords

PROTEIN BAX;

ALLELE; AXONAL INJURY; DISEASE MODEL; GENETIC MANIPULATION; GLAUCOMA; GLIA CELL; HUMAN; INTRAOCULAR PRESSURE; MOLECULAR BIOLOGY; MUTANT; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE; PATHOGENESIS; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; WALLERIAN DEGENERATION;

ASTROCYTE; AXON; BAX; GLAUCOMA; MICROGLIA; OPTIC NERVE; OPTIC NERVE HEAD; RETINAL GANGLION CELL; WLD(S);

ANIMALS; AXONS; GLAUCOMA; HUMANS; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; WALLERIAN DEGENERATION;

EID: 84879844121     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.01.014     Document Type: Review

References (107)

1. Abe N., Cavalli V. Nerve injury signaling. Curr. Opin. Neurobiol. 2008, 18:276-283.
2. Abu-Amero K.K., Morales J., Bosley T.M. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 2006, 47:2533-2541.
3. Adalbert R., Gillingwater T.H., Haley J.E., Bridge K., Beirowski B., et al. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur. J. Neurosci. 2005, 21:271-277.
4. Anderson D.R. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv. Ophthalmol. 1999, 43(Suppl 1):S5-S9.
5. Anderson D.R., Quigley H.A. The Optic nerve. Adler's Physiology of the Eye 1992, 616-640. Mosby Year Book, St Louis. J. WMH (Ed.).
6. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Investig. Ophthalmol. 1974, 13:771-783.
7. Anderson D.R., Hendrickson A.E. Failure of increased intracranial pressure to affect rapid axonal transport at the optic nerve head. Investig. Ophthalmol. Vis. Sci. 1977, 16:423-426.
8. Araki T., Sasaki Y., Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004, 305:1010-1013.
9. Baltmr A., Duggan J., Nizari S., Salt T.E., Cordeiro M.F. Neuroprotection in glaucoma - is there a future role?. Exp. Eye Res. 2010, 91:554-566.
10. Barrientos S.A., Martinez N.W., Yoo S., Jara J.S., Zamorano S., et al. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J. Neurosci. 2011, 31:966-978.
11. Barron M.J., Griffiths P., Turnbull D.M., Bates D., Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 2004, 88:286-290.
12. Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., et al. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 2005, 6:6.
13. Beirowski B., Babetto E., Coleman M.P., Martin K.R. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neurol. 2008, 28:1166-1179.
14. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., et al. Muller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25:397-424.
15. Burgoyne C.F. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp. Eye Res. 2011, 93(2):120-132.
16. Cavalli V., Kujala P., Klumperman J., Goldstein L.S. Sunday Driver links axonal transport to damage signaling. J. Cell Biol. 2005, 168:775-787.
17. Chauhan B.C. Endothelin and its potential role in glaucoma. Can. J. Ophthalmol. 2008, 43:356-360.
18. Chidlow G., Ebneter A., Wood J.P., Casson R.J. The optic nerve heas is the site of axonal transport disruption, axonal cutoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011, 121:737-751.
19. Conforti L., Adalbert R., Coleman M.P. Neuronal death: where does the end begin?. Trends Neurosci. 2007, 30(4):159-166.
20. Crish S.D., Sappington R.M., Inman D.M., Horner P.J., Calkins D.J. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5196-5201.
21. Dai C., Khaw P.T., Yin Z.Q., Li D., Raisman G., Li Y. Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 2012, 60(1):13-28.
22. Dandona L., Hendrickson A., Quigley H.A. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Investig. Ophthalmol. Vis. Sci. 1991, 32:484-491.
23. Deckwerth T.L., Johnson E.M. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 1994, 165:63-72.
24. Del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Koziol J.A. Vascular matrix adhesion and the blood-brain barrier. Biochem. Soc. Trans. 2006, 34:1261-1266.
25. Fernandes K.A., Harder J.M., Fornarola L.B., Freeman R.S., Clark A.F., Pang I.H., John S.W., Libby R.T. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol Dis. (Epub ahead of print) 2012, 10.1016/jnbd.2012.02.003.
26. Gaasterland D., Tanishima T., Kuwabara T. Axoplasmic flow during chronic experimental glaucoma I. Light and electron microscopic studies of the monkey optic nerve head during development of glaucomatous cupping. Investig. Ophthalmol. Vis. Sci. 1978, 17:838-846.
27. Glass J.D., Brushart T.M., George E.B., Griffin J.W. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 1993, 22:311-321.
28. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:714-720. (discussion 829-30).
29. Grimsley C., Ravichandran K.S. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 2003, 13:648-656.
30. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 2007, 179:1523-1537.
31. Howell G.R., Libby R.T., John S.W. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection. Prog. Brain Res. 2008, 173:303-321.
32. Howell G.R., Macalinao D.G., Sousa G.L., Walden M., Soto I., et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 2011, 121:1429-1444.
33. Howell G.R., Walton D.O., King B.L., Libby R.T., John S.W.M. Datgan, a reusable software system for facile interrogation and visualization of complex transcription profiling data. BMC Genomics 2011, 12:429.
34. Ikegami K., Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 2003, 122:617-626.
35. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell Biol. 2005, 171:313-325.
36. Johnson E.C., Morrison J.C. Friend or foe? Resolving the impact of glial responses in glaucoma. J. Glaucoma 2009, 18:341-353.
37. Johnson E.C., Jia L., Cepurna W.A., Doser T.A., Morrison J.C. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Investig. Ophthalmol. Vis. Sci. 2007, 48:3161-3177.
38. Johnson E.C., Doser T.A., Cepurna W.A., Dyck J.A., Jia L., et al. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Investig. Ophthalmol. Vis. Sci. 2011, 52:504-518.
39. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:701-713.
40. Kimelberg H.K., Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010, 7:338-353.
41. Kompass K.S., Agapova O.A., Li W., Kaufman P.L., Rasmussen C.A., Hernandez M.R. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci. 2008, 9:93.
42. Kong G.Y., Van Bergen N.J., Trounce I.A., Crowston J.G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 2009, 18:93-100.
43. Kong Y.X., Van Bergen N., Trounce I.A., Bui B.V., Chrysostomou V., et al. Increase in mitochondrial DNA mutations impairs retinal function and renders the retina vulnerable to injury. Aging Cell 2011, 10:572-583.
44. Kwong J.M., Caprioli J. Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats. Exp. Eye Res. 2006, 82:576-582.
45. Laser H., Conforti L., Morreale G., Mack T.G., Heyer M., et al. The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol. Biol. Cell 2006, 17:1075-1084.
46. Lasker/IRRF Astrocytes and Glaucomatous Neurodegeneration 2010.
47. Levy N.S. The effects of elevated intraocular pressure on slow axonal protein flow. Investig. Ophthalmol. Vis. Sci. 1974, 13:691-695.
48. Libby R.T., Anderson M.G., Pang I.H., Robinson Z.H., Savinova O.V., et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 2005, 22:637-648.
49. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1:17-26.
50. Lindwall C., Kanje M. Retrograde axonal transport of JNK signaling molecules influence injury induced nuclear changes in p-c-Jun and ATF3 in adult rat sensory neurons. Mol. Cell. Neurosci. 2005, 29:269-282.
51. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1989, 1:27-33.
52. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 2001, 4:1199-1206.
53. Martin K.R., Quigley H.A., Zack D.J., Levkovitch-Verbin H., Kielczewski J., et al. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Investig. Ophthalmol. Vis. Sci. 2003, 44:4357-4365.
54. May C.A., Lütjen-Drecoll E. Morphology of the murine optic nerve. Investig. Ophthalmol. Vis. Sci. 2002, 43:2206-2212.
55. McKinnon S.J., Schlamp C.L., Nickells R.W. Mouse models of retinal ganglion cell death and glaucoma. Exp. Eye Res. 2009, 88:816-824.
56. Miller B.R., Press C., Daniels R.W., Sasaki Y., Milbrandt J., DiAntonio A. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat. Neurosci. 2009, 12:387-389.
57. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Investig. Ophthalmol. Vis. Sci. 1977, 16:426-441.
58. Morgan J.E. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye 2000, 14(Pt 3B):437-444.
59. Morgan J.E. Circulation and axonal transport in the optic nerve. Eye (Lond) 2004, 18:1089-1095.
60. Morrison J.C., Johnson E.C., Cepurna W.A., Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog. Retin. Eye Res. 2005, 24:217-240.
61. Murphy J.A., Archibald M.L., Chauhan B.C. The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br. J. Ophthalmol. 2010, 94:1233-1238.
62. Nguyen J.V., Soto I., Kim K.Y., Bushong E.A., Oglesby E., et al. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1176-1181.
63. Nickells, R.W., Howell, G.R., Soto, I., John, S.W., in press. Under pressure: cellular and molecular responses in glaucoma. Ann. Rev. Neuroscience. doi:. doi:10.1146/annurev.neuro.051508.135728.
64. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
65. Nikolskaya T., Nikolsky Y., Serebryiskaya T., Zvereva S., Sviridov E., et al. Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics 2009, 2:24.
66. Osborne N.N. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog. Brain Res. 2008, 173:339-352.
67. Osborne N.N. Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 2010, 90:750-757.
68. Panagis L., Zhao X., Ge Y., Ren L., Mittag T.W., Danias J. Gene Expression Changes in Areas of Focal Loss of Retinal Ganglion Cells (RGC) in the Retina of DBA/2J Mice. Investig. Ophthalmol. Vis. Sci. 2009, 51(4):2024-2034.
69. Pang I.H., Clark A.F. Rodent models for glaucoma retinopathy and optic neuropathy. J. Glaucoma 2007, 16:483-505.
70. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Investig. Ophthalmol. Vis. Sci. 2000, 41:764-774.
71. Pease M.E., Zack D.J., Berlinicke C., Bloom K., Cone F., et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Investig. Ophthalmol. Vis. Sci. 2009, 50:2194-2200.
72. Perry V.H., Lunn E.R., Brown M.C., Cahusac S., Gordon S. Evidence that the rate of Wallerian degeneration is controlled by a single autosomal dominant gene. Eur. J. Neurosci. 1990, 2:408-413.
73. Perry V.H., Brown M.C., Lunn E.R. Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur. J. Neurosci. 1991, 3:102-105.
74. Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:193-201.
75. Prasanna G., Hulet C., Desai D., Krishnamoorthy R.R., Narayan S., et al. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. 2005, 51:41-50.
76. Quigley H.A. The number of persons with glaucoma worldwide. Br. J. Ophthalmol. 1996, 80:389-393.
77. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates I. Production of elevated intraocular pressure by anterior injection of autologous ghost red blood cells. Investig. Ophthalmol. Vis. Sci. 1980, 19:126-136.
78. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Investig. Ophthalmol. Vis. Sci. 1980, 19:137-152.
79. Quigley H.A., Addicks E.M. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch. Ophthalmol. 1981, 99:137-143.
80. Quigley H., Anderson D.R. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Investig. Ophthalmol. 1976, 15:606-616.
81. Quigley H.A., Anderson D.R. Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Investig. Ophthalmol. Vis. Sci. 1977, 16:640-644.
82. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
83. Quigley H.A., Guy J., Anderson D.R. Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch. Ophthalmol. 1979, 97:525-531.
84. Quigley H.A., Addicks E.M., Green W.R., Maumenee A.E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch. Ophthalmol. 1981, 99:635-649.
85. Quigley H.A., Hohman R.M., Addicks E.M., Massof R.W., Green W.R. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am. J. Ophthalmol. 1983, 95:673-691.
86. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Investig. Ophthalmol. Vis. Sci. 2000, 41:3460-3466.
87. Quigley H.A., Cone F.E., Gelman S.E., Yang Z., Son J.L., et al. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice. Exp. Eye Res. 2011, 92:299-305.
88. Radius R.L., Anderson D.R. Rapid axonal transport in primate optic nerve. Arch. Ophthalmol. 1981, 99:650-654.
89. Ribchester R.R., Tsao J.W., Barry J.A., Asgari-Jirhandeh N., Perry V.H., Brown M.C. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur. J. Neurosci. 1995, 7:1641-1650.
90. Ritch R., Shields M.B., Krupin T. The Glaucomas 1996, Mosby, St. Louis.
91. Roberts M.D., Grau V., Grimm J., Reynaud J., Bellezza A.J., et al. Remodeling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma. Investig. Ophthalmol. Vis. Sci. 2009, 50:681-690.
92. Rosen A.M., Stevens B. The role of the classical complement cascade in synapse loss during development and glaucoma. Adv. Exp. Med. Biol. 2010, 703:75-93.
93. Ruiz-Ederra J., Garcia M., Hernandez M., Urcola H., Hernandez B.E., et al. The pig eye as a novel model of glaucoma. Exp. Eye Res. 2005, 81:561-569.
94. Salinas-Navarro M., Alarcon-Martinez L., Valiente-Soriano F.J., Jimenez-Lopez M., Mayor-Torroglosa S., et al. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 2010, 90:168-183.
95. Saragovi H.U., Hamel E., Di Polo A. A neurotrophic rationale for the therapy of neurodegenerative disorders. Curr. Alzheimer Res. 2009, 6:419-423.
96. Sasaoka M., Taniguchi T., Shimazawa M., Ishida N., Shimazaki A., Hara H. Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Exp. Eye Res. 2006, 83:629-637.
97. Schlamp C.L., Li Y., Dietz J.A., Janssen K.T., Nickells R.W. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006, 7:66.
98. Sengupta Ghosh A., Wang B., Pozniak C.D., Chen M., Watts R.J., Lewcock J.W. DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity. J. Cell Biol. 2011, 194:751-764.
99. Shields M.B. Textbook of Glaucoma 1992, Williams & Wilkins, Baltimore.
100. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32(12):638-647.
101. Steele M.R., Inman D.M., Calkins D.J., Horner P.J., Vetter M.L. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Investig. Ophthalmol. Vis. Sci. 2006, 47:977-985.
102. Taniguchi T., Shimazawa M., Sasaoka M., Shimazaki A., Hara H. Endothelin-1 impairs retrograde axonal transport and leads to axonal injury in rat optic nerve. Curr. Neurovasc. Res. 2006, 3:81-88.
103. Tezel G., Yang X., Yang J., Wax M.B. Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res. 2004, 996:202-212.
104. Whitmore A.V., Libby R.T., John S.W.M. Glaucoma: thinking in new ways - a role for autonomous axonal self-destruction and compartmentalised processes?. Prog. Retin. Eye Res. 2005, 24:639-662.
105. Yang Z., Quigley H.A., Pease M.E., Yang Y., Qian J., et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Investig. Ophthalmol. Vis. Sci. 2007, 48:5539-5548.
106. Yang X., Luo C., Cai J., Pierce W.M., Tezel G. Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2008, 49:2483-2494.
107. Yu-Wai-Man P., Griffiths P.G., Chinnery P.F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 2011, 30:81-114.